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Abstract
Background Laparoscopic sleeve gastrectomy (LSG) is
becoming increasingly popular as a stand-alone procedure
for the treatment of morbidly obese patients. A direct
posterior approach to the angle of His was developed at our
department to improve visualization of the difficult dissec-
tion of the short gastric vessels and to facilitate proper
mobilization of the stomach around the left crus enabling
safe realization of a tight sleeve. The technique and its
preliminary results are described.
Methods LSG by posterior approach was performed in a
consecutive series of 445 (110 male/335 female, age 18–
63 years, mean body mass index 46 kg/m2 (range 35–76))
patients between 2007 and 2010.
Results Weight loss defined as mean percent excess weight
loss (%EWL) was 71% (±26%) at 1 year, 69% (±25%) at
2 years, and 55% (±27%) at 3 years. Sixteen patients (4%)
developed postoperative intra-abdominal hematoma,
8 patients (2%) anastomotic leakage, and 6 patients intra-
abdominal abscess (1%), requiring reoperation in 20
patients (4%). Five patients (1%) had pulmonary embolism.
Thirty-day mortality rate was 0.2%.
Conclusions LSG by the posterior approach is a safe and
effective procedure, enabling a tight sleeve formation
leading to satisfactory %EWL results. Since long-term
results of LSG are unknown, further studies are needed to
define the exact place of the LSG as a stand-alone bariatric
procedure.
Keywords Laparoscopic sleeve gastrectomy . Posterior
approach .Morbid obesity . Surgery
Introduction
Laparoscopic sleeve gastrectomy (LSG) is accepted as a
first step bariatric procedure in severe morbidly obese
(body mass index (BMI) >50 kg/m2) patients with high
surgical and anesthesiologic risks [1–3]. The advantages of
LSG are the relative simplicity, satisfying weight loss
results, the lowering of ghrelin levels reducing hunger,
preservation of the normal gastro-intestinal tract without
foreign material, and the absence of gastric strictures
allowing normal dietary options [4–6]. As a result, LSG is
currently gaining popularity as a stand-alone stage bariatric
procedure [7].
From a technical point of view, two LSG techniques
have been described, being the “lateral-to-medial” ap-
proach, whereby stapling is performed after full mobiliza-
tion of the greater curvature [8] and the reverse “medial-to-
lateral” approach where stapling of the complete sleeve is
performed as soon as the lesser sac is entered followed by
full mobilization of the greater curvature [9]. The most
demanding step in this procedure is the dissection of the
short gastric vessels at the angle of His where visualization
can be hampered due to interposition of the stomach or
omentum. Another issue is the fact that all hemorrhage
accumulates in this area leading to poor visualization. This
can result in esophageal injury, a less tight sleeve formation
due to leaving redundant fundus, or bleeding in the splenic
region. To improve visualization at the angle of His, a
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posterior approach has been developed in our department.
Moreover, this approach facilitates proper dissection of the
gastro-pancreatic adhesions at the left crus which is
essential to create a tight sleeve. The primary aim of this
article is to describe the posterior approach and its
preliminary results.
Materials and Method
Between January 2007 and December 2010, 445 consecutive
patients all fulfilling the criteria of the NIH guidelines [10], e.g.,
18–63 years of age and BMI≥40 kg/m2 or ≥35 kg/m2 with
co-morbidities, underwent primary LSG using dorsal ap-
proach in the Sint Franciscus Gasthuis after an intensive
multidisciplinary work-up [11, 12]. Included patients were
335 (75%) women and 110 (25%) men, aged 18 to 63 years
(median age 42 years). Exclusion criteria for LSG were
severe complaints of gastro-esophageal reflux and extreme
sweet eating. Mean pre-operative BMI was 46 kg/m2 (range
35–76). Patient characteristics are described in Table 1.
Statistics
Data were analyzed using the SPSS v. 17.0 statistical program.
Differences between subgroups where analyzed using Mann–
WhitneyU test. The amount of weight loss was expressed as
percentage excess weight loss (%EWL) and calculated with
the formula %EWL ¼ pre operative weight currentð
weightÞ= pre operative weight ideal weightð Þ  100%
[13]. For this formula, a BMI of 25 kg/m2 was taken as the
upper limit of normal, i.e., our ideal weight.
Surgical Technique
The patient is positioned in reverse Trendelenburg in a so-
called French position (i.e., split leg position) with both
arms placed in abduction. Elastic and intermittent pneu-
matic compressing stockings are applied. The surgeon
stands between the patient’s legs, the assistant to the
patient’s left, and the cameraman to the patient’s right.
Phase 0—Trocar Placement Pneumoperitoneum is created
by CO2 insufflation, set at 20 mmHg, through a Verress
needle placed in the left mid-clavicle subcostal region. A
five-port technique is employed: trocar no. 1 (10–12 mm) is
placed 10–15 cm below the xiphoid process slightly left to
the patient’s mid-line (30° angle scope); trocar no. 2 (10–
12 mm) is placed at the location of the Verress needle in the
left upper quadrant (surgeon’s right hand); trocar no. 3 (10–
12 mm) is placed in the right upper quadrant through the
hepatic ligament (surgeon’s left hand); trocar no. 4 (5 mm)
is placed high epigastric in the mid-line (flexible liver
retractor); and trocar no. 5 (5 mm) is placed in the lateral
left abdomen (assistant’s 5-mm Babcock) (Fig. 1).
Phase 1—Mobilization of the Greater Curvature A 5-mm
flexible triangular liver retractor is positioned. The omen-
tum is separated from the greater curvature using a
harmonic scalpel, starting at a location halfway of the
greater curvature, as it is easier to enter the omental bursa at
this area. Possible slight damage of the stomach is not
important at this level as this part is to be resected (Fig. 2).
Further mobilization of the greater curvature is easier with
less chance of bleeding when mobilization is first executed
Table 1 Patient characteristics
Patient characteristics Total n=445
Gender, f/m 335/110
Age, mean (range) 42 (18–63)
BMI kg/m2, mean 46 (±6 SD)
BMI>50 114 (26%)
Co-morbidity
None 190 (43%)
Type 2 diabetes 123 (28%)
Obstructive sleep apnea syndrome 28 (6%)
Hypertension 162 (36%)
Hypercholesterolemia 88 (20%)
Artrosis 44 (10%)
Fig. 1 Schematic view of trocar placement. 1 Optical trocar (left to
the mid-line); 2 operating trocar, surgeon’s right hand; 3 operating
trocar, surgeon’s left hand; 4 liver retractor trocar; 5 assistant’s
stomach trocar
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in an upward direction up to a level just below the spleen,
leaving the small gastric arteries intact (Fig. 3). Next, the
greater curvature is dissected downward to the point where
the stomach is attached to the pancreas (2 cm proximal to
the pylorus) (Fig. 4).
Phase 2—Posterior Mobilization of the Stomach and Angle
of His The assistant grabs the stomach with a 5-mm
Babcock grasper high at the dorso-lateral fundus (no. 5
trocar) and pulls it to the patient’s left as well as in ventral
direction. Next, a 10-mm Babcock grasper (no. 3 trocar) is
placed posterior to the stomach pushing it in the patient’s
right and ventral direction thus creating a tented shaped
configuration of the stomach (Fig. 5). The gastro-pancreatic
adhesions are carefully dissected in the gastro-pancreatic
surgical plane, avoiding damage to the branches of the left
gastric artery, in cranial direction towards the angle of His.
At this point, the dorsal part of the spleen can be visualized,
and the short gastric vessels at the angle of His are
dissected. Then, the 10-mm Babcock is placed dorsal to
the stomach at the angle of His, pushing the stomach to the
patient’s right and ventrally, followed by slight retraction of
this Babcock. This maneuver will further visualize the left
diaphragm crus and the space between the crus and spleen
(Fig. 6). Proper prior posterior gastric mobilization com-
pletely exposing the left crus is important to enable easy
stapling without harming the spleen and without leaving
redundant fundus behind. The crural branch of the left
phrenic vein situated on the left crus in parallel direction
(Fig. 7) can be used as a landmark by dissecting lateral to
this vascular structure in order not to harm the esophagus
when dissecting the angle of His. This applies for the dorsal
as well as the ventral phase (see phase 3). At this point, the
most difficult and dangerous part of the operation is
Fig. 2 Laparoscopic view of the starting point of dissection of the
omentum from the greater curvature of the stomach, thereby entering
the omental bursa
Fig. 3 Laparoscopic view of the mobilization of the greater curvature
in cranial direction to a level just below the spleen
Fig. 4 Laparoscopic view of the dissection in caudal direction up to
the level where the greater curve is attached to the head of the
pancreas (approximately 2–3 cm to the left of the pylorus)
Fig. 5 Laparoscopic view of the gastro-pancreatic adhesions posterior
to the stomach. A tented shaped configuration of the stomach is
created by lifting the stomach to ventrolateral by the assistant’s 5-mm
Babcock. The gastro-pancreatic adhesions are released in upward
direction towards the angle of His
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completed. Alternatively, in superobese patients where
visualization of the dorsal gastric mobilization can be
bothered, the liver retractor can be placed in the bursa
omentalis behind the stomach in order to push the stomach
in ventral direction, thus creating visualization (Fig. 7).
Phase 3—Ventral Mobilization of Angle of His Next, the
ventral aspect of the angle of His is mobilized by dissecting
the peritoneal fold above the Belsy’s fat (at the cardio-
esophageal junction) (Fig. 8). Note that the neurovascular
bundle, mentioned in the previous phase, is easily identified
on the ventral side of the stomach and can be used as a
landmark.
Phase 4—Finalizing Mobilization of the Greater Curvature
by Dissecting the Remaining Small Gastric Vessels Mobi-
lization of the greater curvature is finished by dissection of
the small gastric vessels in cranial direction along the
greater curvature (Fig. 9). Now that the greater curvature is
completely mobilized, the last remaining adhesions of the
Fig. 6 a, b Laparoscopic view of the dorsal mobilization of the angle
of His, thus visualizing the left diaphragm crus and the space between
the crus and the spleen. Asterisks crural branch of left phrenic vein.
Number signs spleen
Fig. 7 Alternatively, the liver retractor (flexible triangular retractor)
can be placed behind the stomach in superobese patients to improve
visualization of dorsal gastric dissection
Fig. 8 a, b Laparoscopic view of the dissection of the ventral aspect
of the angle of His at the cardio-esophageal junction (above the
Belsy’s fat). Asterisks crural branch of left phrenic vein
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stomach at the diaphragmatic crus are released gently in
order not to damage the esophagus (Fig. 10).
Phase 5—Stapling All staplers (60 mm×3.5 mm linear
cutter Echelon, Ethicon, using green cartridge 4.1 mm for
men, gold cartridge 3.8 mm for women) are fired using the
surgeon’s left hand through the patient’s right no. 3 trocar,
as stapling through the contralateral (trocar no. 2) increases
the risk of stapling into the calibration tube. First stapler is
fired at a point 2–3 cm proximal to the pylorus. Before
stapling, the assistant’s 5-mm Babcock (no. 5 trocar) holds
the distal stomach at the greater curvature just proximal to
the left side of the stapler keeping the stapler in place.
Meanwhile, the surgeon uses the 10-mm Babcock with his
right hand to pull the lesser curvature out of the tip of the
stapler in order to make sure that the stomach is not stapled
too narrow at the lesser curve (Fig. 11). After firing the first
stapler, a 34F gastric calibration tube is inserted and guided
over the dorsal side of the stomach along the first stapler
line up to the pylorus (Fig. 12). Since the distal stomach has
been stapled once, the tube will stay in place in the lesser
curvature. Next, another four to five staplers are fired to
finish the gastric sleeve. Before stapling, the assistant’s 5-
mm Babcock grabs the stomach repeatedly at its greater
curvature at a location where the lateral curvature makes a
vault and pulls it to the patient’s caudal and left side. At the
same time, the surgeon pulls the already stapled greater
curve of the stomach caudally with a 10-mm Babcock (no.
2 trocar) while he places the stapler tight to the tube
(Fig. 13). Before firing the stapler, proper dorsal placement
is checked to avoid leaving too much dorsal stomach
volume, which would result in a too wide sleeve.
Furthermore, the 34F tube is moved slightly by the
anesthesiologist under laparoscopic view, focusing on the
tip of the 34F tube, assuring that this tube is not caught
within the stapler. After having fired four to five staplers,
the last stapler is fired less tight to the tube leaving Belsy’s
fat at the gastric sleeve. This avoids stapling into the
esophagus and thereby reduces the chance of anastomotic
leakage (Fig. 14). Staple line bleeding is controlled by the
harmonic scalpel and when necessary with clips.
Phase 6—Removal of Gastric Specimen The specimen is
removed through the patient’s left trocar (no. 2) which is
dilated digitally. Next, the trocar opening is closed with a
suture passed through the fascia by a clamp (Pean clamp),
and local anesthesia (Rapifen) is injected in the fascia at
this location. The gastric 34F tube is now removed under
laparoscopic view by the anesthesiologist without using
suction on the tube in the gastric area until it is in the
esophagus (Fig. 15). In case of bleeding, stapling problems,
or difficult realization of the gastric sleeve, a drain is placed
Fig. 9 Laparoscopic view of the dissection of the greater curve, i.e.,
small gastrics, at the spleen level in order to complete the mobilization
of the greater curve
Fig. 10 a, b Laparoscopic view of the completely mobilized angle of
His, where the last remaining adhesions (asterisks) of the stomach at the
left diaphragmal crus are released very gently in order not to damage the
esophagus, after which the angle of His can be fully stretched (b)
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along the sleeve gastrectomy through the patient’s right
trocar (no. 3).
Postoperative Policy Oral crystal liquids are allowed at the
day of surgery. The next day, only fluids are admitted for
2 weeks. At the first or second postoperative day, the
patient is discharged. CT scan with oral diluted contrast is
performed in patients with early signs of infection (HR
>120/min, (sub)febrile temperature and elevated CRP), but
in case of high suspicion of leakage, a diagnostic
laparoscopy is performed. Gastrografin study and/or gas-
troscopy is performed in case of severe dysphagia or mild
dysphagia lasting more than 3 months postoperatively.
Furthermore, elastic compression stockings (for the dura-
tion of 2 weeks postoperatively) and pneumatic dynamic
leg compression sleeves (for 24 h postoperatively) are used,
and subcutaneous low molecular weight heparin (LMWH)
injection (daily dose of 5,000 U) is administered until
discharge. As a result of a relatively high rate of pulmonary
embolism at the beginning of this study, LMWH is
currently prescribed up until 2 weeks postoperatively. In
addition, a proton pump inhibitor (esomeprazole 40 mg) is
Fig. 12 Schematic view of the insertion of the 34F gastric tube under
assistance of two 10-mm Babcocks guided over the dorsal side of the
stomach along the first stapler line and passed up to the pylorus
Fig. 13 Laparoscopic view of the creation of a tight sleeve by
placement of the stapler tight to the sleeve and pulling the greater
curvature to the patient’s left side using the assistant’s 5-mm Babcock
(no. 5 trocar) placed at a higher level and the surgeon’s 10-mm
Babcock (no. 2 trocar) placed at the already stapled greater curve of
the stomach. Asterisk position of the 34F gastric tube
Fig. 14 Laparoscopic view of the placement (less tight) of the last
stapler at the angle of His, leaving Belsy’s fat (asterisk) at the gastric
sleeve, in order to avoid stapling into the esophagus and thereby
reducing the chance of anastomotic leakage
Fig. 11 Laparoscopic view of the placement of the first stapler by the
surgeon’s left hand through the patient’s right trocar at a location 2–
4 cm proximal to the pylorus. The assistant’s 5-mm Babcock (number
sign) holds the stomach at the greater curvature just proximal to the
left side of the stapler keeping the stapler in place while the surgeon
uses the 10-mm Babcock with his right hand to pull the lesser
curvature (at crows foot (asterisk)) out of the tip of the stapler in order
to make sure that the distal stomach is not stapled to narrow
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applied for 6 weeks to prevent marginal ulcer formation.
Outpatient clinic visits are scheduled at 1, 4, and 12 months
and then every year.
Results
The mean operating time of the dorsal LSGwas 41min (range
19–196). Intra-operative complications were stapling of the
nasogastric tube in two patients (0.4%) of which none required
conversion into a laparoscopic gastric bypass. Operative and
postoperative complications are listed in Table 2.
Sixteen patients (4%) developed postoperative intra-
abdominal hematoma, eight patients (2%) anastomotic
leakage, six patients intra-abdominal abscess (1.3%), and
five patients (1.1%) had pulmonary embolism. Reoperation
for complications was necessary in 20 patients (4.5%) for
leakage (n=4), hematoma (n=12), and intra-abdominal
abscess (n=4). The mean postoperative hospital stay was
2 days (range 1–61). Two patients died (0.4%), one as result
of pulmonary embolism and one as a result of a conversion
operation to gastric bypass for a gastro-cutaneous fistula
9 months after the LSG.
The mean weight change was 41 kg (±15 kg) at 1 year (n=
272), 40 kg (±18 kg) at 2 years (n=105), and 33 kg (±21 kg)
at 3 years (n=40). The mean excess weight loss was 71±
26% (range −7–145) at 1 year, 69±28% (range −11–125) at
2 years, and 55±27% (range −14–107) at 3 years. The
reduction in mean BMI was 14, 14, and 12 kg/m2,
respectively.
Subgroup analysis was performed to compare %EWL
outcome in patients with pre-operative BMI of ≤50 kg/m2
to patients with pre-operative BMI of ≥50 kg/m2, which
showed a significant difference in favor of patients with a
pre-operative BMI of <50 at 1 and 2 years of follow-up
(p<0.001 and p=0.04, respectively). Patients with a pre-
operative BMI of ≤60 kg/m2 also showed significant (p<
0.001) better results in %EWL after 1-year follow-up in
comparison to patients with a pre-operative BMI of
≥60 kg/m2 (Table 3).
Conversion into a laparoscopic Roux-en-Y gastric
bypass (LRYGB) in a later phase (Fig. 16) was necessary
in 16 patients (3.6%), for persisting dysphagia in 2 (0.5%),
and for unsatisfactory weight loss in 14 (3.1%).
After a minimal follow-up period of 1 year (thus
excluding the patients receiving LSG in 2010), type 2
diabetes was cured in 40 patients (47%), improved (reduced
medication) in 15 patients (18%), and unchanged in 30
patients (35%). After 1 year of follow-up, significantly
more patients with a high %EWL (>55%) were cured of
diabetes (n=26 (60%) vs. n=14 (33%), p=0.012). Howev-
er, this significant difference did not sustain at 2 and 3 years
of follow-up.
Fig. 15 Laparoscopic view of the final situation after removal of the
34F gastric tube. There is no redundant gastric fundus at the proximal
sleeve
Table 2 Operation characteristics
Operation characteristics Total n =
445
Conversion to open procedure 0
Peri-operative complications
Minor blood loss 4 (0.9%)
Stapling of 34F gastric tube (corrected laparoscopically) 2 (0.4%)
Minor liver laceration 3 (0.7%)
Minor spleen laceration 3 (0.7%)
Complications
Postoperative complications (in hospital)
Intra-abdominal hematoma 7 (1.6%)
Leakage 5 (1.1%)
Pneumonia 3 (0.7%)
Hematoma of abdominal wall 3 (0.7%)
Reoperation for complications 8 (1.8%)
Gastric stenting for leakage 5 (1.1%)
Mortality (due to pulmonary embolism) 1 (0.2%)
Postoperative complications (<6 weeks after discharge)
Intra-abdominal hematoma 9 (2.0%)
Leakage 3 (0.7%)
Pulmonary embolism (16, 19, 25, and 75 days
postoperatively)
4 (0.9%)
Sustaining dysphagia 9 (2.0%)
Symptomatic cholecystolithiasis 10 (2.2%)
Reoperation for complications 12 (2.7%)
Intra-abdominal abscess 6 (1.3%)
Mortality 1 (0.2%)
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Discussion
LSG is accepted as the first step bariatric procedure (followed
by either duodenal switch or Roux-en-Y gastric bypass) in the
treatment of superobese patients or in patients with high
operative risk [3]. Currently, LSG is becoming increasingly
popular as an isolated operation, because it represents a
relatively straightforward bariatric procedure, resulting in
satisfying weight loss, reduced perception of hunger,
preservation of normal gastro-intestinal tract without foreign
material, and the absence of gastric strictures allowing
normal dietary habits without symptoms of dumping [4–6].
These advantages of LSG and its satisfying weight loss in
the step-up procedure have promoted the use of LSG as a
stand-alone bariatric procedure, resulting in a %EWL
ranging from 47% to 83% (1 year), 47–61% (2 years), 60–
66% (3 years), 58% (4 years) and 55% (5 years) [2, 14–19],
which is comparable with the %EWL of 71% at 1 year, 69%
at 2 years, and 55% at 3 years in this study. Small
prospective series show significant better short-term weight
loss results of LSG in comparison with LRYGB (%EWL
70% vs. 60% at 1 year) as a result of markedly and
consistently reduced ghrelin levels in addition to increased
PYY levels after LSG [20] and comparable improvement in
the metabolic control of diabetes [21, 22]. Nevertheless,
long-term weight loss of this relative new procedure is not
clear as gastric capacity might increase in time.
Realization of a small gastric sleeve seems to be
important as smaller bougie sizes affect weight loss results
and have (according to the LaPlace law) less chance to
dilate [23]. In order to realize a tight sleeve and to avoid
damage to the esophagus and the spleen at the angle of His,
three technical aspects are essential: (1) complete (espe-
cially dorsal) liberation of the gastric fundus (to avoid
redundant fundus), (2) proper traction on the dorsal layer of
the stomach when placing the linear stapler (to avoid
realization of a wide gastric sleeve), and (3) firing of the
final linear stapler slightly lateral to the angle of His (to
avoid encroachment of the esophagus). In bariatric litera-
ture, two different approaches have been described. Gagner
et al. described the lateral-to-medial approach (mobilization
of greater curve followed by stapling) [8], which has the
advantage of optimal calibration of the tight sleeve, but
often the disadvantage of poor visualization of the
dissection of the small gastric vessels at the medial site of
the spleen due to the fact that the stomach and omentum are
blocking the view. Moreover, dissection of the gastrosplenic
ligament can result in bleeding. Hematoma formation at this
dangerous point near the angle of His increases the risk of
damage to the spleen, esophagus, or stomach when
dissecting in that area or when the stapler is placed.
Himpens et al. described the medial-to-lateral approach
(stapling performed as soon as the lesser sac is entered
followed by mobilization of greater curve) [9]. This has the
Table 3 %EWL outcome comparison between pre-operative BMI<50 and BMI>50 and pre-operative BMI<60 and BMI>60
BMI p value
%EWL 1 year, mean (SEM) 76% (1.9), n=196a 56% (2.4), n=76b <0.001
%EWL 2 years, mean (SEM) 71% (3.0), n=74a 61% (4.0), n=31b 0.04
%EWL 3 years, mean (SEM) 55% (5.7), n=25a 56% (7.5), n=15b 0.7
%EWL 1 year, mean (SEM) 72% (1.7), n=244c 48% (3.8), n=28d <0.001
%EWL 2 years, mean (SEM) 69% (2.6), n=100c 58% (5.1), n=5d 0.2
%EWL 3 years, mean (SEM) 55% (4.7), n=39c 62%, n=1d 0.7
SEM standard error of mean
a BMI<50
b BMI>50
c BMI<60
d BMI>60
Dorsal LSG and secondary RYGB
35
59
164 171
5
7
4 0
0
2007 2008 2009 2010
20
40
60
80
100
120
140
160
180
Years
N
um
be
r o
f p
at
ie
nt
s
Fig. 16 Number of LSG procedures per year with number of patients
receiving second step LRYGB after follow-up. Second step LRYGB
numbers in white
OBES SURG (2012) 22:320–329 327
advantage of easier dissection of the small gastric vessels
but the disadvantage of poorer control of achieving a tight
sleeve as it is more difficult to pull the dorsal layer of the
stomach into the stapler. We developed a posterior approach
in which the angle of His is mobilized at the beginning of
the procedure, directly after partial mobilization of the
greater curve and dissection of the dorsal gastro-pancreatic
adhesions in the cranial direction. This approach, in which
the stomach is tented ventrally, has the advantage of better
visualization when dissecting the dorsal angle of His and
the small gastric vessels, thus minimizing the chance of
harming the esophagus, stomach, or spleen. The advantage
of this strategy is the lack of blood loss bothering dissection
and the absence of greater omentum bothering vision. As a
result, proper tight calibration of the sleeve can be easily
performed. Another advantage of this technique is that, due
to its proper visualization and mobilization of the gastro-
pancreatic adhesions, the left gastric artery branches are
well mobilized, thus avoiding the chance of these structures
being damaged within the stapler. Besides gentle dissection
in the angle of His area, it is also important that the final
linear stapler does not staple Belsy’s fat of the gastro-
esophageal junction. This may result in stapling into the
esophagus which results in a higher chance of leakage of
the gastric sleeve at the angle of His due to high intra-
luminal pressure as a result of the restrictive nature of the
procedure. In this large series of LSG procedures, we
experienced this problem in the early years resulting in an
overall 1.8% leakage. In some of these patients (n=2),
staples were observed in the esophagus when endoluminal
stents were placed to control the leakage. Furthermore, we
experienced subphrenic abscess in 0.2%, hematoma in 4%,
and reoperation in 4%. Apart from hematoma, these rates
are comparable to the 0.2%, 0.4%, and 3.6% rates,
respectively, in the study of Frezza et al., wherein LSG
results of a total of 810 patients from 15 studies were
assembled [24]. The higher rate of hematomas was due to
the fact that we tried to reduce the initial higher rate of
pulmonary embolism by a higher LMWH dosage (60 IU/
kg), which was later abandoned as we experienced more
abdominal hematomas. Continuation of administration of
5,000 IU of LMWH for a period of 2 weeks combined with
introduction of dynamic pneumatic leg compression sleeves
perioperatively solved these problems of hematoma and
also of pulmonary embolism, even though the use of high
intra-abdominal pressure (20 mmHg) is still applied for this
procedure. Although expensive, additional use of buttress
material to reinforce the staple line might help further
reduce staple line bleeding [25, 26]. However, the use of the
harmonic scalpel is satisfactory in most cases to control
staple line bleeding. Clips are not routinely used for this
matter as they might cause stapling failure if a gastric
bypass would be required in the future.
Overall mortality rate in this series of 0.4% is also
comparable with the 0.5% in the study of Frezza et al. [24].
Strictures did not occur in this study as opposed to 0.7% in
the study of Frezza et al., and it is suggested to be
associated with oversewing the staple line [1]. In our series,
oversewing was performed at the beginning of the study
and did not prevent anastomotic leakage.
There is a wide range in mean operation time in the
literature for LSG ranging from 25 to 115 min [18, 27]. An
experienced surgeon needs approximately 30 min to
perform dorsal LSG in normal cases ranging to 45 min in
more difficult superobese male patients.
In this study, a marked decline in %EWL after 3 years of
follow-up was noticed when compared to the 1- and 2-year %
EWL results. This could be explained by the surgeon’s
learning curve and the relatively small group of patients with
a follow-up of 3 years, as well as the fact that we becamemore
strict on performing LRYGB for sweet eaters over the last
2 years. However, possible dilatation of the sleeve over the
years and possible change in dietary habits (i.e., more sweet
eating) can also be an explanation for this weight regain.
Patients with a high pre-operative BMI had a signifi-
cantly lower %EWL outcome after 1 and 2 years of follow-
up which is consistent with the results stated in the
literature [23, 28]. Due to the fact that medical costs
become more important, attempts for approval and reim-
bursement for a staged approach in superobese patients is
likely to be met with great resistance. Especially, as with
increased experience and improvements in technique, an
argument can be made for proceeding directly with a LRYGB
as overall morbidity and mortality are comparable with a
staged approach even in patients with BMI>60 kg/m2 [13,
29]. On the other hand, LRYGB is associated with the
discomfort of dumping syndrome and, in some cases, weight
regain or insufficient weight loss [30].
LSG by using the posterior approach offers safe proper
visualization of dissection at the dangerous location at the
angle of His and provides proper mobilization of the dorsal
fundus at the left crus, which facilitates calibration of a tight
gastric sleeve. Based on the satisfactory short-term results
stated in literature, LSG might be a promising bariatric
procedure for certain subgroups of morbidly obese patients.
However, a randomized trial comparing LSG with LRYGB
and/or Lap Band is necessary to determine durability and
long-term merits (%EWL, QOL, Qually’s) of these sub-
groups of morbidly obese patients treated by LSG in
comparison to these other bariatric procedures. Such a trial
is currently under construction by our department.
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